AIMS/HYPOTHESIS: Large quantities of pure viable donor islets are necessary for clinical transplantation. At present, low yields and low viability of pancreatic islets after transplantation necessitate the use of multiple donors for a single recipient. In this study an improved method for obtaining large quantities of pure viable islets of Langerhans for transplantation was developed in the rat. METHODS: Islets of Langerhans were isolated from Albino Oxford rats. The donor pancreata were perfused in situ with iron oxide, which resulted in entrapment of iron particles in the capillaries of the islets. Subsequently, the islets were isolated by magnetic retraction. Islets obtained with this method were compared with islets obtained by density gradient-isolated islets with respect to yields, purity, and insulin production capacity. Islets isolated with the magnetic retraction method were transplanted under the renal capsule of streptozotocin-induced diabetic recipients. Blood-glucose levels in the recipients were monitored for 2 months after transplantation. RESULTS: This method yielded more pure and viable islets than the conventional protocol. No contamination of exocrine tissue was observed after isolation. Furthermore, the islets isolated by magnetic retraction stained strongly positive for insulin during the entire observation period in vitro, and produced high amounts of insulin upon a challenge with glucose. The islets that were obtained by this new protocol were suitable for safe and effective transplantation. CONCLUSIONS/ INTERPRETATION: We have shown that both the quantity and quality of islets obtained with this method were sufficient to induce insulin independence in a diabetic recipient using islets from only one donor.
AIMS/HYPOTHESIS: Large quantities of pure viable donor islets are necessary for clinical transplantation. At present, low yields and low viability of pancreatic islets after transplantation necessitate the use of multiple donors for a single recipient. In this study an improved method for obtaining large quantities of pure viable islets of Langerhans for transplantation was developed in the rat. METHODS: Islets of Langerhans were isolated from Albino Oxford rats. The donor pancreata were perfused in situ with iron oxide, which resulted in entrapment of iron particles in the capillaries of the islets. Subsequently, the islets were isolated by magnetic retraction. Islets obtained with this method were compared with islets obtained by density gradient-isolated islets with respect to yields, purity, and insulin production capacity. Islets isolated with the magnetic retraction method were transplanted under the renal capsule of streptozotocin-induced diabetic recipients. Blood-glucose levels in the recipients were monitored for 2 months after transplantation. RESULTS: This method yielded more pure and viable islets than the conventional protocol. No contamination of exocrine tissue was observed after isolation. Furthermore, the islets isolated by magnetic retraction stained strongly positive for insulin during the entire observation period in vitro, and produced high amounts of insulin upon a challenge with glucose. The islets that were obtained by this new protocol were suitable for safe and effective transplantation. CONCLUSIONS/ INTERPRETATION: We have shown that both the quantity and quality of islets obtained with this method were sufficient to induce insulin independence in a diabetic recipient using islets from only one donor.
Authors: T Linn; K Schneider; H P Hammes; K T Preissner; H Brandhorst; E Morgenstern; F Kiefer; R G Bretzel Journal: FASEB J Date: 2003-03-28 Impact factor: 5.191
Authors: T Fujioka; P I Terasaki; R Heintz; N Merideth; R P Lanza; T L Zheng; P Soon-Shiong Journal: Transplantation Date: 1990-02 Impact factor: 4.939
Authors: Y F Smets; R G Westendorp; J W van der Pijl; F T de Charro; J Ringers; J W de Fijter; H H Lemkes Journal: Lancet Date: 1999-06-05 Impact factor: 79.321
Authors: M D Rizzari; T M Suszynski; L S Kidder; S A Stein; T D O'Brien; V S K Sajja; W E Scott; V A Kirchner; B P Weegman; E S Avgoustiniatos; P W Todd; D J Kennedy; B E Hammer; D E R Sutherland; B J Hering; K K Papas Journal: Transplant Proc Date: 2010-12 Impact factor: 1.066
Authors: Rustin M Shenkman; Jeffrey J Chalmers; Bernhard J Hering; Nicole Kirchhof; Klearchos K Papas Journal: Tissue Eng Part C Methods Date: 2009-06 Impact factor: 3.056
Authors: Zhigang Wang; Andrew Brown; Pascal André; Stuart I Brown; Gordon J Florence; Alfred Cuschieri Journal: Biomed Res Int Date: 2013-11-12 Impact factor: 3.411
Authors: Bradley P Weegman; Venkata Sunil Kumar Sajja; Thomas M Suszynski; Michael D Rizzari; William E Scott Iii; Jennifer P Kitzmann; Kate R Mueller; Thomas R Hanley; David J Kennedy; Paul W Todd; Appakalai N Balamurugan; Bernhard J Hering; Klearchos K Papas Journal: J Diabetes Res Date: 2016-10-23 Impact factor: 4.011